Aspira Women’s Health (NASDAQ:AWH) Announces Quarterly Earnings Results

Aspira Women’s Health (NASDAQ:AWH) posted its earnings results on Monday. The company reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.04, Yahoo Finance reports. The firm had revenue of $2.42 million during the quarter, compared to the consensus estimate of $2.60 million. During the same quarter in the prior year, the business posted ($0.28) earnings per share.

Aspira Women’s Health Price Performance

Shares of AWH opened at $1.36 on Wednesday. Aspira Women’s Health has a 1 year low of $0.86 and a 1 year high of $6.75. The company has a market capitalization of $16.93 million, a price-to-earnings ratio of -0.75 and a beta of 1.54. The business has a 50-day moving average of $1.45 and a 200-day moving average of $2.81.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Aspira Women’s Health from a “sell” rating to a “hold” rating in a research report on Wednesday.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.